Published in Inorg Chem on May 10, 2008
FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination. Cell (2009) 4.11
The mitochondrial calcium uniporter is a multimer that can include a dominant-negative pore-forming subunit. EMBO J (2013) 1.86
USP15 is a deubiquitylating enzyme for receptor-activated SMADs. Nat Cell Biol (2011) 1.61
Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors. Chembiochem (2007) 1.37
Central nicotinic receptors: structure, function, ligands, and therapeutic potential. ChemMedChem (2007) 1.36
Effects of magnesium and related divalent metal ions in topoisomerase structure and function. Nucleic Acids Res (2009) 1.32
Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery. Curr Top Med Chem (2008) 1.32
Insight into 2-phenylpyrazolo[1,5-a]pyrimidin-3-yl acetamides as peripheral benzodiazepine receptor ligands: synthesis, biological evaluation and 3D-QSAR investigation. Bioorg Med Chem (2005) 1.26
Protein kinase CK2 inhibitors: a patent review. Expert Opin Ther Pat (2012) 1.21
Novel symmetric and asymmetric DNA scission determinants for Streptococcus pneumoniae topoisomerase IV and gyrase are clustered at the DNA breakage site. J Biol Chem (2005) 1.19
Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study. Biochemistry (2004) 1.16
Anion binding by protonated forms of the tripodal ligand tren. Inorg Chem (2009) 1.15
Toward the rational design of protein kinase casein kinase-2 inhibitors. Pharmacol Ther (2002) 1.15
Aminoacyl-anthraquinone conjugates as telomerase inhibitors: synthesis, biophysical and biological evaluation. J Med Chem (2008) 1.10
MG-2477, a new tubulin inhibitor, induces autophagy through inhibition of the Akt/mTOR pathway and delayed apoptosis in A549 cells. Biochem Pharmacol (2011) 1.09
DNA interaction with Ru(II) and Ru(II)/Cu(II) complexes containing azamacrocycle and dppz residues. A thermodynamic, kinetic and theoretical study. Dalton Trans (2010) 1.09
Quinone methides tethered to naphthalene diimides as selective G-quadruplex alkylating agents. J Am Chem Soc (2009) 1.04
Hot-spot consensus of fluoroquinolone-mediated DNA cleavage by Gram-negative and Gram-positive type II DNA topoisomerases. Nucleic Acids Res (2007) 1.02
Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2. Biochem J (2009) 1.02
Discovery of novel A3 adenosine receptor ligands based on chromone scaffold. Biochem Pharmacol (2012) 0.99
Synthesis, biological properties, and molecular modeling investigation of the first potent, selective, and water-soluble human A(3) adenosine receptor antagonist. J Med Chem (2002) 0.99
The evolving world of protein-G-quadruplex recognition: a medicinal chemist's perspective. Biochimie (2011) 0.99
Hemolytic effects of water-soluble fullerene derivatives. J Med Chem (2004) 0.98
Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonists. J Med Chem (2002) 0.98
Swimming into peptidomimetic chemical space using pepMMsMIMIC. Nucleic Acids Res (2011) 0.97
The quinolone family: from antibacterial to anticancer agents. Curr Med Chem Anticancer Agents (2003) 0.97
Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: A complete structure-activity profile. Purinergic Signal (2006) 0.96
A dynamic G-quadruplex region regulates the HIV-1 long terminal repeat promoter. J Med Chem (2013) 0.96
Photogeneration and reactivity of naphthoquinone methides as purine selective DNA alkylating agents. J Am Chem Soc (2010) 0.96
MMsINC: a large-scale chemoinformatics database. Nucleic Acids Res (2008) 0.96
Small molecule inhibitors of histone arginine methyltransferases: homology modeling, molecular docking, binding mode analysis, and biological evaluations. J Med Chem (2007) 0.95
Evidence for the Recognition of Non-Nucleotide Antagonists Within the Transmembrane Domains of the Human P2Y(1) Receptor. Drug Dev Res (2002) 0.95
New water soluble pyrroloquinoline derivatives as new potential anticancer agents. Bioorg Med Chem (2005) 0.94
Mortality among discharged psychiatric patients in Florence, Italy. Psychiatr Serv (2006) 0.94
Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application. J Med Chem (2006) 0.94
GTP-dependent packing of a three-helix bundle is required for atlastin-mediated fusion. Proc Natl Acad Sci U S A (2011) 0.94
New anti-human immunodeficiency virus type 1 6-aminoquinolones: mechanism of action. Antimicrob Agents Chemother (2003) 0.94
Binol quinone methides as bisalkylating and DNA cross-linking agents. J Am Chem Soc (2004) 0.92
In front of and behind the replication fork: bacterial type IIA topoisomerases. Cell Mol Life Sci (2010) 0.92
Hybrid ligand-alkylating agents targeting telomeric G-quadruplex structures. Org Biomol Chem (2012) 0.92
Prevalence, tumorigenic role, and biochemical implications of rare BRAF alterations. Thyroid (2014) 0.92
Toward efficient Zn(II)-based artificial nucleases. J Am Chem Soc (2004) 0.91
Novel fluorescent antagonist as a molecular probe in A(3) adenosine receptor binding assays using flow cytometry. Biochem Pharmacol (2012) 0.91
CO(2) Fixation by Novel Copper(II) and Zinc(II) Macrocyclic Complexes. A Solution and Solid State Study. Inorg Chem (1996) 0.91
A fluorescent chemosensor for Zn(II). Exciplex formation in solution and the solid state. Dalton Trans (2004) 0.91
A thermodynamic insight into the recognition of hydrophilic and hydrophobic amino acids in pure water by aza-scorpiand type receptors. Org Biomol Chem (2015) 0.89
Inhibition of human immunodeficiency virus type 1 tat-trans-activation-responsive region interaction by an antiviral quinolone derivative. Antimicrob Agents Chemother (2004) 0.89
Design of Ligands That Stabilize Cu(I) and Shift the Reduction Potential of the Cu(II/I) Couple Cathodically in Aqueous Solutions. Inorg Chem (1999) 0.89
SAR and QSAR study on 2-aminothiazole derivatives, modulators of transcriptional repression in Huntington's disease. Bioorg Med Chem (2008) 0.89
Structure modifications of 6-aminoquinolones with potent anti-HIV activity. J Med Chem (2004) 0.88
Novel camptothecin derivatives as topoisomerase I inhibitors. Expert Opin Ther Pat (2009) 0.88
2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a new scaffold to obtain potent and selective human A3 adenosine receptor antagonists: new insights into the receptor-antagonist recognition. J Med Chem (2009) 0.88
Formation of a unique cluster of G-quadruplex structures in the HIV-1 Nef coding region: implications for antiviral activity. PLoS One (2013) 0.87
Interactions of flavones and other phytochemicals with adenosine receptors. Adv Exp Med Biol (2002) 0.87
A BINOL-based chiral polyammonium receptor for highly enantioselective recognition and fluorescence sensing of (S,S)-tartaric acid in aqueous solution. Chem Commun (Camb) (2012) 0.87
Quantitative correlation of solvent polarity with the alpha-/3(10)-helix equilibrium: a heptapeptide behaves as a solvent-driven molecular spring. Angew Chem Int Ed Engl (2003) 0.87
Bridging molecular docking to membrane molecular dynamics to investigate GPCR-ligand recognition: the human A₂A adenosine receptor as a key study. J Chem Inf Model (2014) 0.86
Involvement of p53 in specific anti-neuroectodermal tumor activity of aloe-emodin. Int J Cancer (2003) 0.86
How druggable is protein kinase CK2? Med Res Rev (2010) 0.86
Clerocidin alkylates DNA through its epoxide function: evidence for a fine tuned mechanism of action. Nucleic Acids Res (2003) 0.86
Autophagy acts as a safeguard mechanism against G-quadruplex ligand-mediated DNA damage. Autophagy (2012) 0.86
Amide bond direction modulates G-quadruplex recognition and telomerase inhibition by 2,6 and 2,7 bis-substituted anthracenedione derivatives. Bioorg Med Chem (2007) 0.86
Inhibition of protein kinase CK2 by anthraquinone-related compounds. A structural insight. J Biol Chem (2002) 0.86
alpha-Naphthylaminopropan-2-ol Derivatives as BACE1 Inhibitors. ChemMedChem (2008) 0.85
The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein. Antimicrob Agents Chemother (2010) 0.85
Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents. J Med Chem (2003) 0.85
DNA gyrase requires DNA for effective two-site coordination of divalent metal ions: further insight into the mechanism of enzyme action. Biochemistry (2008) 0.85
Heterocyclic dications as a new class of telomeric G-quadruplex targeting agents. Curr Pharm Des (2012) 0.85
Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based homology modeling as a computational strategy to depict the pyrazolo-triazolo-pyrimidine antagonists binding site of the human adenosine A2A receptor. J Chem Inf Model (2008) 0.85
Spectroscopic, molecular modeling, and NMR-spectroscopic investigation of the binding mode of the natural alkaloids berberine and sanguinarine to human telomeric G-quadruplex DNA. ACS Chem Biol (2012) 0.85
Adenosiland: walking through adenosine receptors landscape. Eur J Med Chem (2012) 0.84
The A3 adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approaches. Med Res Rev (2011) 0.84
BINOL-amino acid conjugates as triggerable carriers of DNA-targeted potent photocytotoxic agents. J Med Chem (2007) 0.84
A synthetic hexapeptide designed to resemble a proteinaceous P-loop nest is shown to bind inorganic phosphate. Proteins (2012) 0.84
The crystal structure of human telomeric DNA complexed with berberine: an interesting case of stacked ligand to G-tetrad ratio higher than 1:1. Nucleic Acids Res (2012) 0.84